Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.

A NEW injection that could prevent HIV infection has successfully completed an early safety trial, according to a report in ...

Salesh Jindal, senior vegetable breeder, department of vegetable science, said that CH-27 is a high-yielding hybrid, with ...

A new study led by Western researchers is the first to identify a factor that could influence how fast the pocket where human ...

Mount Sinai researchers have developed a method to uncover the hidden immune cells that harbor the human immunodeficiency virus (HIV), a discovery that brings medical experts one step closer to a cure ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

HIV prevention has advanced with lenacapavir, a yearly injection that blocks the virus's replication, providing long-term ...

A groundbreaking annual injection designed to protect against HIV has successfully passed its first safety trial, bringing new hope for long-term prevention.The drug, Lenacapavir, prevents the virus ...

Interest in vitamin A is booming as Americans seek alternative treatments for measles. While the essential nutrient has a ...

The drug, which works by blocking HIV from entering and multiplying in human cells, remained in the body for at least 56 ...

A Lancet study shows promising results for an annual HIV prevention injection, lenacapavir. In Stage 1 trials, 40 HIV-negative participants had no significant side effects ...